Summary
Insulin autoantibodies, like islet cell antibodies, are found not only in the sera of newly diagnosed Type 1 (insulin-dependent) diabetic patients and their relatives, but also in patients with other autoimmunities who do not develop diabetes. Insulin autoantibodies are oligo/monoclonal and frequently binding-site restricted. As determinant selection is genetically determined, we questioned whether certain polymorphisms of insulin autoantibodies, identified by their binding site on the insulin molecule, could better discriminate for Type 1 diabetes, which is also HLA determined. First, we raised monoclonal antibodies to human insulin by classic fusion methods in order to determine the range of antibody polymorphism, and identified five distinct types by their binding profiles to a panel of insulin variants, using an enzyme-linked immunosorbent assay. Two of these polymorphisms, type A and type B, were subsequently found in insulin autoantibody positive human sera using the same panel of insulin variants, and successfully distinguished diabetes-related from diabetes-unrelated individuals. Thus, the type B polymorphism was responsible for binding in 60% of 41 insulin autoantibody positive individuals with polyautoimmune disease but no personal or family history of diabetes (diabetes unrelated), but in only 2% of a group which comprised 17 newly-diagnosed insulin autoantibody positive Type 1 diabetic patients, 19 insulin autoantibody positive discordant twins of Type 1 diabetes and six insulin autoantibody positive healthy siblings of Type 1 diabetic patients (diabetes related) (p<0.01). Isolation of the type A polymorphism alone reduced the proportion of false negatives in the insulin autoantibody test for diabetes relatedness from 49% to 20% without diminishing its specificity. Thus, insulin autoantibody polymorphisms are more discriminating than the ‘nominal’ antibody, due possibly to linkage between immune response genes determining response to the type A epitope on the one hand, and susceptibility to Type 1 diabetes on the other.
Article PDF
Similar content being viewed by others
References
Hirata Y, Ishizu H, Ouchi N, Motomura S, Abe M, Hara Y, Wagasugi H, Takahashi I, Sakano H, Tanaka M, Kawano H, Kanesaki T (1970) Insulin autoimmunity in a case of spontaneous hypoglycaemia. J Jap Diab Soc 13: 312–320
Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Pacquette TL (1983) Insulin antibodies in insulin dependent diabetics before insulin treatment. Science 222: 1337–1339
Wilkin TJ, Hoskins PJ, Armitage M, Rodier M, Casey C, Diaz J-L, Pyke DA, Leslie RDG (1985) Value of insulin autoantibodies as serum markers for insulin dependent diabetes mellitus. Lancet I: 480–482
Srikanta S, Ricker AT, McCullock DK, Soeldner JS, Eisenbarth GS, Palmer JP (1986) Autoimmunity to insulin, beta cell dysfunction and development of insulin dependent diabetes. Diabetes 35: 139–142
Wilkin TJ, Nicholson S (1984) Autoantibodies against human insulin. Br Med J 288: 349–352
Diaz JL, Wilkin TJ (1987) Differences in antigen restriction of autoantibodies to native human insulin (IAA) and antibodies to heterologous insulins (IA). Diabetes 36: 66–72
Rosenthal AS, Barcinski MA, Blake JT (1977) Determinant selection is a macrophage-mediated immune response gene function. Nature 267: 156–158
Cudworth AG, Woodrow JC (1975) Evidence for HLA-A linked genes in juvenile diabetes mellitus. Br Med J 3: 133–135
Mirza IH, Wilkin TJ, Cantarini M, Moore K (1987) A comparison of spleen and lymph node cells as fusion partners for the raising of monoclonal antibodies after different routes of immunisation. J Immunol Methods 105: 235–243
Wilkin TJ, Nicholson S, Casey C (1985) A micro-enzyme linked immunosorbent assay for insulin antibodies in serum. J Immunol Methods 76: 185–194
Axen R, Porath J, Ernback S (1967) Chemical coupling of peptides and proteins to polysaccharides by means of cyanogenhalides. Nature 214: 1302–1304
Storch MJ, Licht T, Petersen KG, Obermeier R, Kerp L (1987) Specificity of monoclonal anti-human insulin antibodies. Diabetes 36: 1005–1009
Bottazzo GF, Pujol-Borrell R, Doniach D (1981) Humoral and cellular immunity in diabetes mellitus. Clin Immunol Allergy 1: 139–159
Thomas DW, Schauster JL, Hoffman MD, Wilner GD (1985) Nonrandom catabolism of proteins in the formation of antigen peptide fragments. J Immunol 135: 1259–1263
Arquilla ER, Finn J (1963) Genetic differences in antibody production to determinant groups of insulin. Science 142: 400–401
Cudworth AG, Bottazzo GF, Doniach D (1980) Genetic and immunological factors in type I diabetes mellitus. In: Irvine WJ (ed) Immunology of diabetes. Teviot, Edinburgh, pp 67–99
Phillips ML, Yip CC, Sherach EM, Delovitch TL (1986) Photoaffinity labelling demonstrates binding between Ia molecules and nominal antigen on antigen-presenting cells. Proc Natl Acad Sci USA 83: 5634–5638
Chan CTJ, Byfield PGH, Himsworth RL, Shepherd P (1987) Human autoantibodies to thyroglobulin are directed towards a restricted number of human specific epitopes. Clin Exp Immunol 70: 516–523
Shoenfeld Y, Isenberg DA, Ranch J, Madaio MP, Stollar BD, Schwartz RS (1984) Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet II: 417–422
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wilkin, T., Mirza, I., Armitage, M. et al. Insulin autoantibody polymorphisms with greater discrimination for diabetes in humans. Diabetologia 31, 670–674 (1988). https://doi.org/10.1007/BF00278750
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00278750